APTOCROM Inc. (KOSDAQ:109960)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,828.00
+3.00 (0.16%)
At close: Jun 9, 2026
Market Cap20.25B -73.9%
Revenue (ttm)8.89B -45.6%
Net Income-7.48B
EPS-598.31
Shares Out 11.04M
PE Ration/a
Forward PEn/a
Dividend150.00 (8.22%)
Ex-Dividend DateDec 29, 2025
Volume22,353
Open1,808.00
Previous Close1,825.00
Day's Range1,808.00 - 1,875.00
52-Week Range1,793.00 - 11,820.00
Beta-0.13
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About APTOCROM

APTOCROM Inc. distributes pharmaceutical products in South Korea. It operates through pharmaceutical business, leasing business, and insulation divisions. The company is involved in design, manufacturing, and construction of insulation; design, manufacturing and installation of removable insulation materials; design, production, and construction of nuclear power plant special insulation; and foam glass insulation material molding and construction. It also offers medicines for the digestive system, including ijilong solution, gabespan soft capsu... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1998
Employees 14
Stock Exchange KOSDAQ
Ticker Symbol 109960
Full Company Profile

Financial Performance

In 2025, APTOCROM's revenue was 9.81 billion, a decrease of -40.20% compared to the previous year's 16.40 billion. Losses were -5.56 billion, -80.21% less than in 2024.

Financial Statements